Considerations for Impella vs. ECMO

February 26, 2019

Dr. Michael Tong, Director of Heart Transplantation; Dr. Edward Soltesz, Surgical Director; and Dr. Shinya Unai, Cardiovascular and Thoracic Surgeon all of the Cleveland Clinic join Dr. Dan Raess to discuss considerations for when ECMO is the right choice and when Impella is the right choice for their patients. Clinicians today have different mechanical circulatory support (MCS) strategies available. This roundtable addresses how to determine the best MCS selection tailored for that patient.

Dr. Soltesz outlines patient presentation and decision-making strategies. Dr. Tong discusses the importance of ambulation with Impella 5.0 for patients who are being evaluated for bridge to surgery. He also discusses the importance of venting the ventricle and Impella’s ability to decrease the afterload on the heart for patients on ECMO. Dr. Unai highlights the importance of timing for venting and transitioning patients off of ECMO while on Impella support. The group also outlines the clinical care team for ECMO and Impella patients.

Tune in to hear from the panel about their strategy for MCS selection, patient management, and venting.



Subscribe, or join the conversation by following us on Twitter: @ProtectedPCI

To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: